Muscle Pharm Corporation (MSLPQ)

[StocksAnonymous]

Excerpt from Wynnefield Capital Management sc 13d 04/21/15:

The Wynnefield Reporting Persons have recently communicated their dissatisfaction with certain corporate governance practices of the Issuer to the Issuer’s Board of Directors (the “Board”). The Wynnefield Reporting Persons are pleased that the Issuer announced today that it was addressing a number of these issues – confirming its intent to separate the roles of Chairman and CEO by December 31, 2015. The Wynnefield Reporting Persons will continue to monitor the Issuer’s progress in achieving these objectives.

This tells me that Wynnefield still sees value in the shares and is becoming an active shareholder. Both are positives for shareholders.